Related Experiment Video
Updated: May 19, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Activation likelihood estimation of convergent resting-state brain alterations in diarrhea-predominant IBS: a
Xiaojuan Ma1, Yanguo Zhu2, Yiqiong Ma3
1Department of Surgical Oncology, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, China.
Background:
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common functional gastrointestinal disorder. Resting-state functional magnetic resonance imaging (rs-fMRI) has provided valuable insights into brain activity alterations; however, despite the increasing number of neuroimaging studies, the results remain inconsistent. This study aimed to perform a coordinate-based activation likelihood estimation (ALE) meta-analysis to identify functionally impaired brain regions showing convergent alterations in IBS-D.
Methods:
Coordinate-based ALE was applied to rs-fMRI studies of IBS-D that were systematically retrieved from multiple databases. Statistical significance was determined using cluster-level family-wise error correction, and the robustness of the results was further evaluated through a jackknife sensitivity analysis.
Results:
The ALE meta-analysis revealed two clusters of hyperactivity in IBS-D patients compared to healthy controls (HCs). The first cluster was located in the right cerebellar culmen (69.4%), extending to the right cerebellar lingula (7.7%) and left fastigial nucleus (22.9%). The second cluster was located in the right parahippocampal gyrus [78.6%, Brodmann area (BA) 36], extending to the right fusiform gyrus (18.6%) and right sub-gyral area of the parahippocampal gyrus (2.8%). In contrast, one cluster of hypoactivity was observed in the right superior frontal gyrus (67.6%, BA 10) and right middle frontal gyrus (32.4%, BAs 9 and 10). The jackknife sensitivity analysis confirmed the robustness of these clusters across all iterations.
Conclusions:
This ALE meta-analysis identified functionally impaired brain regions consistently altered in IBS-D, providing novel insights into its central mechanisms and potential targets for future research and therapeutic interventions.
Related Concept Videos
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management

